NIH heroin addiction treatment

guidelines, 209

outcome monitoring, 153-160 passim, 167, 168, 169

pregnant women, 36

Alcohol and Drug Research Study, 37

Alcohol and Drug Services Survey, 187-197

Alcoholics Anonymous, 24, 27-29, 85, 138, 140, 160, 162-164, 169, 175

Aliviane, 77

American Cancer Society, 46

American Heart Association, 46

American Lung Association, 46

American Medical Association, 62, 200

American Psychiatric Association, 61

American Society of Addiction Medicine, 61, 100, 161

Amphetamines, see Methamphetamines

Antabuse (disulfiram), 167, 169, 242

Antidepressants, 170

Anxiolytic buspirone, 170

Arapaho House Comprehensive Substance Abuse Treatment Center, 73-75, 78, 79, 82

Arizona, 20

ASI, see Addiction Severity Index

Asians/Pacific Islanders, 139, 194, 244

Assessment methodology, see Evaluation methodology;

Quality control

Attitudes, vi

AA members, 27-29

abuser motivation, 33, 50, 80, 156-157, 162, 163, 175, 235, 241-242, 247

contingency management, 34

methadone maintenance, 32, 49-50

researchers, 77, 98

research subjects, 98, 99

self-esteem, 80

stigma, 9, 11, 16, 17, 25, 32, 46-48, 49-50, 116, 153, 205, 210, 213

treatment facilities placement, local residents, 38, 46, 47, 49-50

trust building, xv, 3, 5, 56, 57, 66-70, 74, 98, 112

B

Barbiturates, 194

Behavioral interventions, 2, 6, 7, 18, 19, 20, 24, 59, 67, 74, 86, 150, 164-165, 170-171

NIH heroin addiction treatment guidelines, 202, 208, 209

see also Contingency management;

Counseling and counselors;

Group therapy

Benzodiazepines, 194

Biopsychological factors, vii,6, 16, 17, 80

methamphetamine abuse, 229

opiate addiction, 200-201, 203-204, 212

outcome analysis, 152

recovering addicts, 149

see also Drugs to treat abusers;

Genetic factors;

Medical interventions;

Mental illness;

Withdrawal

Black persons, see African Americans

Block grants, 7, 17, 27, 42-43, 65, 114, 197

methadone, 31

Buprenorphine, 49, 151, 166, 207, 209

C

California, 20, 22, 35, 36

Cancer treatment, 11, 46, 68-69, 96, 100-102, 107

cost-effectiveness, 5, 101, 112

see also Community Clinical Oncology Program

Case management, 34, 74, 97, 173, 238, 248, 250

CASPAR, 102

CBOs, see Community-based drug treatment organizations

CCOP, see Community Clinical Oncology Program

Center for Mental Health Services, 95

Center for Substance Abuse Prevention, 94-95

Center for Substance Abuse Treatment, v, vii, 9, 17-18, 116, 124, 231

collaborative research support, 10, 13-15, 18, 74, 94, 100, 117-118, 120

definitional issues, 23

technology transfer, 58, 59-60, 115, 120, 136

treatment protocols, list of approved, 233-234

Center on Alcohol, Substance Abuse, and Addiction, 20, 96, 98-99, 108

Certification, see Licensing and certification

Chestnut Health Systems and Interventions, 99, 107



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement